Press release
MedVi Expands Access to GLP-1 Medication - Compounded Semaglutide for Healthy Living
NEWARK, DE - MedVi Wellness, a leading telehealth provider in medical weight management, has announced the launch of its nationwide GLP-1 medication program, providing compounded semaglutide in both injectable and oral forms. Starting at $179 per month with no insurance required, MedVi [https://medvi.io] offers an affordable, physician-guided alternative to high-cost brand-name drugs such as Wegovy Registered and Ozempic Registered .
The GLP-1 medication program combines compounded semaglutide with continuous clinical oversight, 24/7 support, and fast delivery, giving patients an accessible path to sustainable weight loss backed by medical expertise.
GLP-1 Medications Driving a New Era in Weight Management
Semaglutide, a GLP-1 receptor agonist, works by reducing appetite, improving satiety, and stabilizing blood sugar levels. Clinical studies show that GLP-1 medications can help patients achieve 15-18% average weight reduction over time when combined with healthy lifestyle changes.
"GLP-1 medications like semaglutide have redefined medical weight loss," said a MedVi Wellness spokesperson. "By offering compounded semaglutide at an affordable price point with physician oversight, we are eliminating the barriers that keep most patients from accessing this transformative therapy."
Key Features of MedVi's GLP-1 Medication Program
*
Compounded Semaglutide Injections - Once-weekly dosing with pre-filled pens
*
Oral Semaglutide Tablets - A non-injectable option for daily use
*
Physician-Supervised Treatment - Personalized dosing plans from board-certified providers
*
Continuous Monitoring and Support - Unlimited check-ins and 24/7 medical access
*
Fast, Nationwide Delivery - Temperature-controlled shipping direct to patients
MedVi's program also includes GLP-1 medication for blood sugar control, benefiting patients managing type 2 diabetes while addressing weight and metabolic health together.
Addressing Drug Shortages and Rising Demand
Due to ongoing shortages of brand-name GLP-1 drugs like Wegovy Registered and Ozempic Registered , compounded semaglutide has become a vital alternative. MedVi sources exclusively from FDA-regulated, PCAB-accredited compounding pharmacies, ensuring pharmaceutical-grade standards and verified potency.
"By combining GLP-1 medication expertise with streamlined telehealth delivery, MedVi is meeting demand where traditional healthcare has fallen short," the spokesperson added. "Patients no longer need to wait months or pay thousands for care."
Why MedVi?
*
GLP-1 medications starting at $179/month
*
FDA-regulated compounding facilities and U.S.-licensed physicians
*
Transparent, no-membership pricing
*
Money-back guarantee with ongoing medical guidance
*
Service availability in all 50 U.S. states
How It Works
*
Online Medical Evaluation: Complete a secure health assessment at medvi.io [https://medvi.org/intakeform.php?uid=1&oid=5&affid=8&afid=seo&pub=5000].
*
Physician Review: A board-certified provider approves treatment if medically appropriate.
*
Medication Delivery: GLP-1 medication ships directly to the patient's home, with instructions included.
*
Ongoing Support: MedVi provides unlimited consultations, dose adjustments, and 24/7 access to licensed clinicians.
About MedVi Wellness
MedVi Wellness is a U.S.-based telehealth platform dedicated to weight loss and metabolic care through GLP-1 medications. By pairing clinical expertise with convenience and affordability, MedVi empowers patients to achieve lasting health results with doctor-led guidance and transparent pricing.
Media Contact
Company Name: MedVi Wellness
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living]
Phone: (323) 690-1564
Address:131 Continental Dr. Ste 305
City: Newark
State: DE 19713
Country: United States
Website: http://medvi.io
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MedVi Expands Access to GLP-1 Medication - Compounded Semaglutide for Healthy Living here
News-ID: 4127122 • Views: …
More Releases from ABNewswire
The Silver Clover & Co. Redefines Anniversary Gifting Through Personalized Jewel …
Jewelry retailer addresses common gift-giving anxiety by pairing timeless pieces with message cards that help express emotions words alone cannot capture.
The jewelry retail landscape welcomes a thoughtful innovation as The Silver Clover & Co. addresses a universal challenge faced by anniversary gift-givers: how to convey the depth of years spent together through a single present. Through its unique combination of carefully curated jewelry, personalized message cards, and luxury presentation packaging,…
Diabetic Macular Edema Pipeline 2025: Innovative Clinical Developments by 45+ Gl …
Diabetic Macular Edemacompanies are Unity Biotechnology, Therini Bio, Valo Health, Kyowa Kirin, Invirsa, Frontera Therapeutics, EyePoint Pharmaceuticals, EyeBiotech, EnnovaBio, Eclipse Life Sciences, Merck, Rezolute, Aviceda Therapeutics, KODIAK SCIENCES, AsclepiX Therapeutics, and others.
As Diabetic Macular Edema (DME) becomes increasingly prevalent worldwide and contributes to comorbidities such as diabetes, cardiovascular disease, and certain cancers, there is a rising demand for safer and more effective treatment options. DelveInsight reports that more than 45…
Royal Window Treatments Expands Window Upholstery in New York Services with Enha …
Royal Window Treatments celebrates 20 years of serving Manhattan by expanding its Hunter Douglas products, offering motorized shades, custom blinds, and expert installation for NYC homes and offices.
After more than two decades of serving Manhattan residents, Royal Window Treatments [https://www.google.com/maps/place/Royal+Window+Treatments/@40.736962,-73.9847553,683m/data=!3m2!1e3!4b1!4m6!3m5!1s0x89c25909f3cf88eb:0x1f91d68f43f25072!8m2!3d40.736962!4d-73.9847553!16s%2Fg%2F1tvm3pcf!5m1!1e1?entry=ttu&g_ep=EgoyMDI1MTAxNC4wIKXMDSoASAFQAw%3D%3D] announces an expanded selection of premium window covering solutions, including an extensive collection of Hunter Douglas products. The Midtown Manhattan-based company continues to address the unique challenges faced by New…
Triad Electric Solutions Adopts Advanced Thermal Imaging Technology to Reduce El …
Triad Electric Solutions implements thermal imaging technology, reducing electrical diagnostic time by 50% while improving safety and accuracy for customers throughout the North Carolina Triad region.
Local electrical contractor Triad Electric Solutions has implemented state-of-the-art thermal imaging technology across its operations, significantly improving diagnostic capabilities and reducing service call duration. The Greensboro-based company, led by owner David Angel, reports that the new technology has cut electrical repair [https://maps.google.com/maps?ll=36.116673,-79.783811&z=16&t=m&hl=en&gl=PH&mapclient=embed&cid=8975902741359798768&q=electrical+repair&oq=electrician+near+me] diagnostic time in…
More Releases for MedVi
MedVi Unveils Its Cheaper Compounded GLP-1 Weight Management Medication Alternat …
Affordable telehealth platform offers cost-saving GLP-1 medication options for Americans seeking to manage weight without breaking the bank-physician-supervised care starting at just $179 per month.
Image: https://www.abnewswire.com/upload/2025/10/58a28bbefc869a8ec591ab5122e76187.jpg
United States - As brand-name GLP-1 medications like Wegovy and Ozempic continue to carry monthly costs exceeding $1,000 without insurance, MedVi today released a comprehensive overview of cheaper, compounded alternatives available to American patients. With over 500,000 patients served, MedVi addresses the critical question: Which…
MEDVi Personalized GLP-1 Medication Review - Is This the Future of Weight Loss a …
MEDVi Personalized GLP-1 Medication Review - Is This the Future of Weight Loss and Diabetes Management?
Introduction: Why Everyone's Talking About Personalized GLP-1 Medications
In today's fast-moving world of health innovation, one major trend is dominating Google searches and health forums alike-personalized GLP-1 medications. With the rise of obesity, prediabetes, and insulin resistance across all age groups, more people than ever are looking for smarter, science-backed solutions that deliver real results without…
MEDVi Revolutionizes Fitness Goals with Affordable, Doctor-Prescribed GLP-1 Medi …
Newark, Delaware - MEDVi, a leading provider of doctor-prescribed weight loss solutions, is making cutting-edge GLP-1 treatments accessible to millions across the United States. With medications like Semaglutide and Tirzepatide available for as low as $179 per month without insurance, MEDVi is transforming the weight loss industry by offering affordable, science-backed solutions.
With over 500,000 patients benefiting from its personalized programs, MEDVi provides individuals with a practical, medically supervised approach to…
